Mynd ai Inc 뉴스 - MYND | 주식 아메리카 증권거래소 | ADVFN

다우존스 지수

무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

등록

Mynd ai Inc (MYND)

1.8801

0.1501

(8.68%)

종가: 21 12월 6:00AM

1.8992

0.0191

( 1.02% )

시간외 거래: 7:11AM

개인 투자자를 위한 전문가급 도구.

Mynd.ai's Promethean Brand to Release Transformational New Technology in First Quarter of 2025

Mynd.ai's Promethean Brand to Release Transformational New Technology in First Quarter of 2025 PR Newswire SEATTLE, Nov. 4, 2024 SEATTLE, Nov. 4...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Mynd.ai Announces $10 Million Share Repurchase Program

Mynd.ai Announces $10 Million Share Repurchase Program PR Newswire SEATTLE, Oct. 21, 2024 SEATTLE, Oct. 21, 2024 /PRNewswire/ -- Mynd.ai, Inc...

Promethean wins Tech & Learning Awards of Excellence: Back to School 2024

Promethean wins Tech & Learning Awards of Excellence: Back to School 2024 PR Newswire SEATTLE, Oct. 14...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Mynd Announces 2024 First Half Results

Mynd Announces 2024 First Half Results PR Newswire SEATTLE, Aug. 29, 2024 Gross Margins Increased 100 Basis Points to 27.3%; Adjusted EBITDA loss...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form EFFECT - Notice of Effectiveness

Form 424B3 - Prospectus [Rule 424(b)(3)]

Promethean's ActivPanel LX wins a Tech & Learning Best of Show Award at the ISTELive 24 edtech conference

Promethean's ActivPanel LX wins a Tech & Learning Best of Show Award at the ISTELive 24 edtech...

Form F-3 - Registration statement by foreign private issuers

Promethean's ActivPanel LX is honored by the 2024 EdTech Breakthrough Awards

Promethean's ActivPanel LX is honored by the 2024 EdTech Breakthrough Awards PR Newswire SEATTLE, June 6, 2024...

Mynd Announces Fiscal Year 2023 Results

Mynd Announces Fiscal Year 2023 Results PR Newswire SEATTLE, March 27, 2024 Delivers Revenue of $413.6 Million and Successfully Completes...

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

santafe2

santafe2 1 분 전

Notes from Beth Kindig who I like with regard to her tech background and advice over the last few years. I'm not saying this is gospel, but I do think she's correct here. Broadcom stunned the market with a nearly 40% surge in two days on optimism that the company would quickly become the #2 behind t

harry crumb

harry crumb 2 분 전

Pick yur ins/outs, greed always loses! $$$$$

richme

richme 2 분 전

improvement in fibromyalgia pain with a p-value of 0.00005 So based on this definition, .000000000005, would still be significant?

MoneyMan

MoneyMan 2 분 전

Great day. On Pink Current watch......

primecomm

primecomm 3 분 전

Locked and Loaded- $1+++ Next Week $$$$$$$$$$$$$$$

nwsun

nwsun 4 분 전

Remember when BERKSHIRE AGENT use to pump this then he left 11/1)23.

primecomm

primecomm 5 분 전

$TXNP will rise next week! $$$$$

trainer2

trainer2 5 분 전

Your post in meaningless at best.

1vman

1vman 6 분 전

*****🚽HIRU🚽 Bad Times 19 Million - XPERT sells W👀w

https://ih.advfn.com/stock-market/USOTC/hiru-pk-HIRU/trades

ENOUGH SAID HUIZZAH !!!!🖕

Lonewolf1

Lonewolf1 6 분 전

STAY - THE - COURSE!

Tick tock........

gfp927z

gfp927z 6 분 전

>>> Novo Nordisk Stock Crashes on Obesity Drug Data. It’s a Win for Eli Lilly.

Barron's

by Josh Nathan-Kazis

Dec 20, 2024

https://www.barrons.com/articles/novo-nordisk-stock-data-eli-lilly-9c83e0d5?siteid=yhoof2

Golf4Food

Golf4Food 6 분 전

Take the emotion out of trading and you’ll do fine, kid.

kickedoffagain

kickedoffagain 6 분 전

An opportunity to excel/ deliver.

gfp927z

gfp927z 7 분 전

>>> Novo Nordisk Stock Crashes on Obesity Drug Data. It’s a Win for Eli Lilly.

Barron's

by Josh Nathan-Kazis

Dec 20, 2024

https://www.barrons.com/articles/novo-nordisk-stock-data-eli-lilly-9c83e0d5?siteid=yhoof2

TenKay

TenKay 7 분 전

“…and "recapitaliztion" can be vague. We have no proof of anything yet.“

Which is EXACTLY why that term gets used in the pinks.

I have been following OTC stocks for 14 years…so well over 100 stocks.

I have never seen the term “recapitalization” used whe

gfp927z

gfp927z 7 분 전

>>> Novo Nordisk Stock Crashes on Obesity Drug Data. It’s a Win for Eli Lilly.

Barron's

by Josh Nathan-Kazis

Dec 20, 2024

https://www.barrons.com/articles/novo-nordisk-stock-data-eli-lilly-9c83e0d5?siteid=yhoof2

Chartmaster

Chartmaster 7 분 전

That KEY REVERSAL WEEK a few weeks back held the low! Now we're back above the 50 day!

AUhills

AUhills 8 분 전

The real question here is how good are the chances $TNXP's new fibromyalgia drug gets approved? Read here: "With TNX-102 SL treatment, patients in Tonix's studies experienced less pain, the company says. In the most recent phase 3 trial, called RESILIENT, TNX-102 SL showed a statistically significa

moczowy

moczowy 8 분 전

Let's hope it's the right girl so we can come LOL

fuagf

fuagf 8 분 전

Step aside, buy some snacks, relax, and watch. if you miss out on some goodies, who cares, it's the long game that counts.

Good advice.

https://www.usnews.com/object/image/00000193-e00b-d021-a1bf-ffbf0d530000/20241217edbbc-a.jpg?update-time=1734630896011&size=responsi

primecomm

primecomm 8 분 전

Just come back. What happened here?

igotthemojo

igotthemojo 8 분 전

“ Jason Few seems to care about 45V.”

It’s in his best interest to hope that 45v will be wonderful…and don’t you know, that’s exactly the “rumblings” he’s hearing from the street….huh…imagine that!…

And guess what?…he sees nothing but wonderful opportunities down the ro

exwannabe

exwannabe 8 분 전

Moot point, as the next scheduled activity for the Northwest Biotherapeutics, Inc. v. Citadel Securities LLC case is a status conference set for January 15, 2025.
Wrong court case, that is Phumeware v BOA.

Further, that has already been cancelled as the defendants as expected a

kennyt 335

kennyt 335 9 분 전

Lmao, l once hit a guy in the arm and told him that was a flea he struck me back knocked me a couple step backwards and said horsefly lol Merry Christmas my friend🎄

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관